California Public Employees Retirement System Collegium Pharmaceutical, Inc Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$21.74 - $25.28 $1.53 Million - $1.77 Million	-70,200 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$19.25 - $26.1 $125,356 - $169,963	-6,512 Reduced 8.49%	70,200 $1.66 Million
Q4 2020 Feb 02, 2021	SELL	$17.83 - $22.29 $26,744 - $33,435	-1,500 Reduced 1.92%	76,712 $1.54 Million
Q3 2020 Nov 05, 2020	BUY	$15.78 - $20.82 $14,612 - $19,279	926 Added 1.2%	78,212 $1.63 Million
Q2 2020 Aug 12, 2020	BUY	$15.49 - $23.51 $90,523 - $137,392	5,844 Added 8.18%	77,286 $1.35 Million
Q1 2020 May 12, 2020	BUY	$13.89 - $25.45 $175,014 - $320,670	12,600 Added 21.41%	71,442 $1.17 Million
Q4 2019 Jan 27, 2020	BUY	$10.7 - $22.24 $463,309 - $962,991	43,300 Added 278.6%	58,842 $1.21 Million
Q3 2019 Oct 31, 2019	BUY	$10.16 - $13.28 $40,253 - $52,615	3,962 Added 34.21%	15,542 $178,000
Q2 2019 Aug 15, 2019	BUY	$10.62 - $16.59 $122,979 - $192,112	11,580 New	11,580 $152,000

Others Institutions Holding COLL

# of Institutions

249

Shares Held

36.2M

Call Options Held

100K

Put Options Held

21.1K

Black Rock Inc. New York, NY

5.79M
Shares

$189 Million
0.0% of portfolio
Eventide Asset Management, LLC Boston, MA

2.64M
Shares

$85.9 Million
1.79% of portfolio
Vanguard Group Inc Valley Forge, PA

2.35M
Shares

$76.5 Million
0.0% of portfolio
Pacer Advisors, Inc. Malvern, PA

2.14M
Shares

$69.8 Million
0.15% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

1.66M
Shares

$54 Million
0.1% of portfolio

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.11B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account